Transcatheter mitral valve-in-valve for pregnancy with anti-phospholipid syndrome: a case report.
Humans
Female
Pregnancy
Antiphospholipid Syndrome
/ complications
Mitral Valve
/ surgery
Adult
Heart Valve Prosthesis Implantation
/ methods
Pregnancy Complications, Cardiovascular
/ surgery
Bioprosthesis
Heart Valve Prosthesis
Cesarean Section
Cardiac Catheterization
/ methods
Mitral Valve Insufficiency
/ surgery
Prosthesis Failure
Anti-phospholipid syndrome
Pregnancy
Transcatheter mitral valve-in-valve
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
19 Jun 2024
19 Jun 2024
Historique:
received:
08
11
2023
accepted:
27
03
2024
medline:
20
6
2024
pubmed:
20
6
2024
entrez:
19
6
2024
Statut:
epublish
Résumé
Perioperative management and cardiac surgery in pregnant women with anti-phospholipid syndrome combined with heart valve disease have been rarely reported. We describe a case of transcatheter mitral valve-in-valve replacement in a pregnant woman with bioprosthetic valve failure and anti-phospholipid syndrome at 18 weeks' gestation. The patient underwent a cesarean section delivery at 34 weeks of gestation, resulting in the birth of a healthy baby. Transapical mitral valve-in-valve surgery resulted in safe maternal and infant outcomes in a pregnant woman with anti-phospholipid syndrome combined with mitral bioprosthetic valve failure. The success of this procedure underscored the importance of multidisciplinary teamwork.
Sections du résumé
BACKGROUND
BACKGROUND
Perioperative management and cardiac surgery in pregnant women with anti-phospholipid syndrome combined with heart valve disease have been rarely reported.
CASE PRESENTATION
METHODS
We describe a case of transcatheter mitral valve-in-valve replacement in a pregnant woman with bioprosthetic valve failure and anti-phospholipid syndrome at 18 weeks' gestation. The patient underwent a cesarean section delivery at 34 weeks of gestation, resulting in the birth of a healthy baby.
CONCLUSIONS
CONCLUSIONS
Transapical mitral valve-in-valve surgery resulted in safe maternal and infant outcomes in a pregnant woman with anti-phospholipid syndrome combined with mitral bioprosthetic valve failure. The success of this procedure underscored the importance of multidisciplinary teamwork.
Identifiants
pubmed: 38898495
doi: 10.1186/s13019-024-02702-1
pii: 10.1186/s13019-024-02702-1
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
335Subventions
Organisme : Basic and Applied Basic Research Foundation of Guangdong Province
ID : 2019B1515120071
Organisme : National Natural Science Foundation of China
ID : 82270373
Informations de copyright
© 2024. The Author(s).
Références
Johnson MZ, Damianopoulos NJ, Lee F, Yong G. Mitral valve-in-valve implantation during pregnancy. BMJ Case Rep. 2021;14:e244270. https://doi.org/10.1136/bcr-2021-244270 .
doi: 10.1136/bcr-2021-244270
pubmed: 34815226
pmcid: 8611431
Ribeyrolles S, Diakov C, Veugeois A, Berrebi A, Caussin C. Transcatheter mitral valve-in-valve implantation: an option for failed bioprosthetic mitral valve stenosis during pregnancy. JACC Case Rep. 2020;2:145–9. https://doi.org/10.1016/j.jaccas.2019.11.050 .
doi: 10.1016/j.jaccas.2019.11.050
pubmed: 34316983
pmcid: 8301506
Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78:1296–304. https://doi.org/10.1136/annrheumdis-2019-215213 .
doi: 10.1136/annrheumdis-2019-215213
pubmed: 31092409
Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74:1011–8. https://doi.org/10.1136/annrheumdis-2013-204838 .
doi: 10.1136/annrheumdis-2013-204838
pubmed: 24464962
Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ. 2023;380:e069717. https://doi.org/10.1136/bmj-2021-069717 .
doi: 10.1136/bmj-2021-069717
pubmed: 36849186
Pilato E, Pinna GB, Grande L, Cirillo V, Izzo R, Tufano A, et al. Challenging report of cardiopulmonary bypass in 16th week pregnant patient with endoventricular mass. Heart Lung J Crit Care. 2021;50:174–6. https://doi.org/10.1016/j.hrtlng.2020.05.008 .
doi: 10.1016/j.hrtlng.2020.05.008
Migliorini S, Santoro C, Scatteia A, Dellegrottaglie S, Tufano A, Cuomo V, et al. A rare case of tricuspid valve Libman-Sacks endocarditis in a pregnant woman with primary antiphospholipid syndrome. J Clin Med. 2022;11:5875. https://doi.org/10.3390/jcm11195875 .
doi: 10.3390/jcm11195875
pubmed: 36233742
pmcid: 9573308
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–241. https://doi.org/10.1093/eurheartj/ehy340 .
doi: 10.1093/eurheartj/ehy340
pubmed: 30165544
Arnoni RT, Arnoni AS, Bonini RCA, De Almeida AFS, Neto CA, Dinkhuysen JJ, et al. Risk factors associated with cardiac surgery during pregnancy. Ann Thorac Surg. 2003;76:1605–8. https://doi.org/10.1016/S0003-4975(03)01188-3 .
doi: 10.1016/S0003-4975(03)01188-3
pubmed: 14602295
Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli FR, Perricone C, et al. A Monocentric Cohort of Obstetric Seronegative Anti-phospholipid Syndrome. Front Immunol. 2018;9:1678. https://doi.org/10.3389/fimmu.2018.01678 .
doi: 10.3389/fimmu.2018.01678
pubmed: 30079071
pmcid: 6062588
Tyler B, Walford H, Tamblyn J, Keay SD, Mavrelos D, Yasmin E, et al. Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses. Hum Reprod Update. 2022;28:480–500. https://doi.org/10.1093/humupd/dmac009 .
doi: 10.1093/humupd/dmac009
pubmed: 35325124
pmcid: 9631462